Anne Talkington1, Claudia Dantoin2, Rick Durrett3
1Bioinformatics and Computational Biology, University of North Carolina, Chapel Hill, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Engineered T cells targeting CD19 show success in treating acute lymphocytic leukemias. Mathematical models predict this adoptive immunotherapy can effectively eliminate tumors, moving patients to a state of remission.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: